
MTC does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for MTC and 80,000+ other tickers.
See exactly how MTC's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MTC and 80,000+ other tickers.
MMTec, Inc., together with its subsidiaries, develops and deploys platforms that enable financial institutions to engage in securities market transactions and settlements worldwide. It operates in two segments: Gujia, MM Future, HC Securities; and MM Global. The company offers securities dealers trading system, which supports securities registration and clearing, account management, risk management, trading and execution, and third-party access middleware; private fund investment management system, which supports multi-account management, fund valuation, risk management, quantitative trading…

BILLERICA, Mass.--(BUSINESS WIRE)--Javelin Biotech today announced a landmark scientific publication, titled "Interconnected multi-microphysiological systems and PBPK modeling for predicting human pharmacokinetics”, in the "Breakthrough" special issue of Lab on a Chip. The study details a liver-centric multi-tissue chip (MTC) platform designed to capture the complex pharmacokinetic (PK) profiles of small-molecule drugs. The research marks a significant demonstration of how combinatorial NAMs en.

Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in w

Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demo

MMTec, Inc. (NASDAQ: MTC - Get Free Report)'s share price was down 6.9% during mid-day trading on Monday. The company traded as low as $3.20 and last traded at $3.22. Approximately 42,251 shares were traded during trading, a decline of 57% from the average daily volume of 98,074 shares. The stock had previously closed at

HONG KONG , Dec. 11, 2025 /PRNewswire/ -- MMTEC, Inc. (NASDAQ: MTC) ("MMTEC", "we", "our" or the "Company"), a China-based technology company that provides access to the U.S. financial markets, today announced that on December 9, 2025, the Company received a decision letter (the "Decision Letter") from the Nasdaq Hearings Panel of The Nasdaq Stock Market LLC ("Nasdaq"). The Company previously received a determination letter (the "Determination Letter") which advised that for the 30 consecutive business days prior to the date of the Determination Letter the minimum closing bid price per share for the Company's common stock was below the $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule").